Total Payments
$4,818
2023 Payments
$21.57
Companies
30
Transactions
339
Medicare Patients
11,692
Medicare Billing
$749,173
Payment Breakdown by Category
Food & Beverage$4,801 (99.7%)
Consulting$16.83 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,801 | 338 | 99.7% |
| Consulting Fee | $16.83 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $698.65 | 80 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $595.84 | 35 | $0 (2023) |
| Amgen Inc. | $545.20 | 39 | $0 (2022) |
| Medtronic Vascular, Inc. | $383.05 | 8 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $337.01 | 21 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $291.43 | 48 | $0 (2021) |
| HeartFlow, Inc. | $186.97 | 2 | $0 (2021) |
| Amarin Pharma Inc. | $185.76 | 11 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $148.54 | 9 | $0 (2022) |
| Arbor Pharmaceuticals, Inc. | $140.72 | 11 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $21.57 | 1 | Novartis Pharmaceuticals Corporation ($21.57) |
| 2022 | $533.74 | 31 | Novartis Pharmaceuticals Corporation ($123.53) |
| 2021 | $1,045 | 66 | Novartis Pharmaceuticals Corporation ($279.79) |
| 2020 | $226.64 | 15 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($81.15) |
| 2019 | $938.06 | 66 | Janssen Pharmaceuticals, Inc ($267.37) |
| 2018 | $1,211 | 113 | Amgen Inc. ($224.21) |
| 2017 | $842.74 | 47 | Medtronic Vascular, Inc. ($204.48) |
All Payment Transactions
339 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/29/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Diabetes | ||||||
| 06/24/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Verquvo (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Cardio-pulmonary | ||||||
| 06/20/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Cardiovascular | ||||||
| 06/16/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: DIABETES | ||||||
| 05/16/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/11/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2022 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Cardiac Rhythm Management | ||||||
| 05/04/2022 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Cardiac Rhythm Management | ||||||
| 05/04/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiovascular | ||||||
| 05/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 04/27/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: DIABETES | ||||||
| 04/13/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/06/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/30/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 03/22/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardiovascular | ||||||
| 03/14/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/01/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/01/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Cardiology | ||||||
| 02/22/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 26 | 2,647 | 7,091 | $657,006 | $140,938 |
| 2021 | 37 | 5,176 | 9,994 | $1.4M | $346,658 |
| 2020 | 32 | 3,869 | 8,641 | $1.0M | $261,577 |
Total Patients
11,692
Total Services
25,726
Medicare Billing
$749,173
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 445 | 445 | $304,825 | $58,629 | 19.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 223 | 223 | $115,291 | $27,690 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 204 | 224 | $23,520 | $10,622 | 45.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 694 | 796 | $23,880 | $4,690 | 19.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 83 | 84 | $17,220 | $4,136 | 24.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 24 | 24 | $14,565 | $3,826 | 26.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 54 | 69 | $11,178 | $3,794 | 33.9% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2022 | 24 | 24 | $10,080 | $2,916 | 28.9% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 235 | 411 | $12,741 | $2,772 | 21.8% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 16 | 16 | $9,792 | $2,763 | 28.2% |
| 71275 | Ct scan of blood vessels of chest with contrast | Office | 2022 | 14 | 14 | $17,010 | $2,596 | 15.3% |
| 75635 | Ct scan of abdominal aorta and both leg arteries with contrast | Office | 2022 | 13 | 13 | $20,176 | $2,349 | 11.6% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2022 | 17 | 18 | $9,000 | $2,016 | 22.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 78 | 116 | $10,672 | $1,939 | 18.2% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2022 | 14 | 44 | $7,832 | $1,616 | 20.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 78 | 116 | $8,700 | $1,577 | 18.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 170 | 182 | $9,100 | $1,369 | 15.0% |
| 93308 | Ultrasound of heart, follow-up | Office | 2022 | 16 | 16 | $3,392 | $1,101 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $2,210 | $1,001 | 45.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,510 | $996.55 | 28.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 26 | $2,210 | $690.48 | 31.2% |
| 85610 | Blood test, clotting time | Office | 2022 | 72 | 122 | $2,684 | $520.13 | 19.4% |
| 93279 | Programming of single lead pacemaker system | Office | 2022 | 14 | 17 | $2,329 | $488.45 | 21.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2022 | 37 | 3,981 | $11,943 | $381.63 | 3.2% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 2022 | 36 | 42 | $1,050 | $243.50 | 23.2% |
About Dr. David Prewitt, MD
Dr. David Prewitt, MD is a Cardiovascular Disease healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1871580316.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Prewitt, MD has received a total of $4,818 in payments from pharmaceutical and medical device companies, with $21.57 received in 2023. These payments were reported across 339 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,801).
As a Medicare-enrolled provider, Prewitt has provided services to 11,692 Medicare beneficiaries, totaling 25,726 services with total Medicare billing of $749,173. Data is available for 3 years (2020–2022), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Plano, TX
- Active Since 09/30/2005
- Last Updated 08/11/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1871580316
Products in Payments
- XARELTO (Drug) $698.65
- ENTRESTO (Drug) $556.97
- LifeVest (Device) $337.01
- Livalo (Drug) $291.43
- Repatha (Biological) $290.60
- Corlanor (Drug) $254.60
- Advisa (Device) $204.48
- Vascepa (Drug) $185.76
- Azure (Device) $165.82
- BRILINTA (Drug) $148.54
- FFRct (Device) $144.90
- ELIQUIS (Drug) $133.39
- KENGREAL (Drug) $120.55
- WATCHMAN (Device) $112.95
- Edarbyclor (Drug) $87.78
- Micra (Device) $82.85
- PRALUENT (Drug) $81.44
- PRALUENT ALIROCUMAB INJECTION (Biological) $77.19
- Rybelsus (Drug) $67.86
- VERQUVO (Drug) $63.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Plano
Srinivasa Potluri, Md, MD
Cardiovascular Disease — Payments: $783,265
Cardiovascular Disease $783,265
Dr. David Brown, M.d, M.D
Cardiovascular Disease — Payments: $256,750
Cardiovascular Disease $256,750
David Rawitscher, Md, MD
Cardiovascular Disease — Payments: $244,805
Cardiovascular Disease $244,805
Sahil Bakshi, Do, DO
Cardiovascular Disease — Payments: $193,440
Cardiovascular Disease $193,440
Mordecai Klein, Md, MD
Cardiovascular Disease — Payments: $162,433
Cardiovascular Disease $162,433
Dr. Vijay Ramanath, M.d, M.D
Cardiovascular Disease — Payments: $123,142
Cardiovascular Disease $123,142